Study Design
SECONDARY
This secondary analysis reports on a secondary outcome from the Immediate Parent-Infant Skin-to-Skin Study (IPISTOSS), a randomized clinical trial with 2 parallel, nonblinded groups conducted between April 1, 2018, and June 30, 2021.